Symmetry Medical Inc. SMA announced today preliminary unaudited revenue for the full year ended January 1, 2011.
Symmetry anticipates full year 2010 revenue of approximately $361 million, in line with previously issued guidance of $360 to $364 million.
For the full year 2011, the Company issued revenue guidance of $363 to $383 million, representing annual growth of approximately 1% to 6%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in